Clinical trials: in Benin
Tuberculosis
A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis
Tuberculosis is currently treated with a 6-month course regimen. During this time many patients might fail to adhere to treatment and default, increasing the risk of recurrent disease which might be multidrug resistant.
- Trial name
- NCT00216385
- Testing
- Gatifloxacin combined regimen
- Where
- 5 sites in Benin, Guinea and 3 more
- Volunteers
- 2,070 people
- Sponsor
- Institut de Recherche pour le Developpement